Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Radspherin - Oncoinvent

Next Previous
Search
Drug Profile

Radspherin - Oncoinvent

Alternative Names: 224-calciumcarbonate-microparticles - Oncoinvent; 224Ra-CaCO3-MP - Oncoinvent; Alpha-emitting radionuclide therapy - Oncoinvent; Ra-224 based therapeutic - Oncoinvent; Radium-224 based therapeutic - Oncoinvent; Radspherin®

Latest Information Update: 08 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Oncoinvent
  • Class Antineoplastics; Radioisotopes; Radiopharmaceuticals; Small molecules
  • Mechanism of Action Ionising radiation emitters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Colorectal cancer; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer

Most Recent Events

  • 08 Apr 2025 Oncoinvent initiates enrollment in a phase-II clinical trials in Fallopian tube cancer, Ovarian cancer, Peritoneal cancer (Late-stage disease, Metastatic disease, Neoadjuvant therapy) in United Kingdom, Spain, Norway, Belgium, USA (Intraperitoneal) (NCT06504147)
  • 05 Dec 2024 Oncoinvent plans a phase IIb trial for Ovarian cancer (First-line therapy) in USA (Intraperitoneal) in H2 2025
  • 11 Nov 2024 Efficacy data from a phase I/IIa trial in Colorectal cancer released by Oncoinvent

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top